Cardiothoracic & vascular anesthesia

Continuous Intertransverse Process Block Versus Continuous Paravertebral Block for Postoperative Analgesia After Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Trial

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Primary result · 48-hour morphine consumptionResult — go to the resultMean difference 1.0 mg 95% CI −0.39 to 2.45

Authors' conclusion

Continuous ITPB resulted in similar 48-hour morphine consumption, pain scores, and complication rates to continuous PVB for VATS, together with a shorter time to perform the block. However, the non-inferiority of ITPB to PVB was not statistically confirmed.

Study context

Population
Adults undergoing elective video-assisted thoracoscopic surgery (VATS) at a university hospitalenrolled
Participants
55 adults
Comparison
Continuous intertransverse process block (ITPB) vs continuous paravertebral block (PVB)
  • ITPBn = 25
  • PVBn = 25reference
Primary endpoint
Total morphine consumption
Follow-up
First 48 postoperative hours
Methodological detailsdouble-blind, non-inferiority, single-centre
  • Double-blind
  • Non-inferiority
  • Single-centre

Primary result

48-hour morphine consumption · 48 hours

Mean difference

1.0 mg

95% CI −0.39 to 2.45

P = 0.151

By group

ITPB vs PVB
mean difference 1.0 mg (95% CI −0.39 to 2.45); P = 0.151

Non-inferiority margin 1 as printed, not drawn

As reported in the abstract

Secondary outcomes

Block performance time · shorter with ITPB

P < 0.001

Visual analog scale (VAS) at rest and with deep breathing · all time points

Comparable at all time points
P > 0.05 for all

Original publication

Continuous Intertransverse Process Block Versus Continuous Paravertebral Block for Postoperative Analgesia After Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Trial. J Cardiothorac Vasc Anesth. Published 3 August 2026. doi:10.1053/j.jvca.2026.07.056

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.